Neurodynamic of the Human Brain Underlying Animal-assisted Intervention in Healthy Adults
NCT ID: NCT05837546
Last Updated: 2023-07-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2023-05-01
2023-07-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electrophysiological Signatures of Distinct Working Memory Subprocesses That Predict Long-term Memory Success
NCT05892419
Study of Electroencephalogram (EEG) Measurement During Different Stimulations of the Lower Urinary Tract
NCT01389921
Physiology of Weakness in Movement Disorders
NCT00307346
Brain Changes Associated With Learning a Motor Task
NCT00076466
Proactive and Reactive Attention to Negative Templates
NCT06068712
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
As control conditions the investigators use a replica therapy dog (Joy for All) and a condition with no dog but the presence of a plant. The plant was chosen as to control for the mere presence and engagement with an object and because the impact of the presence of a plant in the frontal brain electrical activity has been studied before. In both control conditions, the intervention will be as similar as possible to the real dog condition with a physical contact between the object and the participants.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Real dog
presence of a real dog, contact with participant for 5 minutes
Animal-assisted intervention
presence of a dog, contact between dog and participant
replica dog
presence of a replica dog, contact with participant for 5 minutes
Factice dog intervention
presence of a factice dog, contact between factice dog and participant
plant
presence of a plant, contact with participant for 5 minutes
Plant intervention
presence of a plant, contact between plant and participant
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Animal-assisted intervention
presence of a dog, contact between dog and participant
Factice dog intervention
presence of a factice dog, contact between factice dog and participant
Plant intervention
presence of a plant, contact between plant and participant
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years
Exclusion Criteria
* Any acute or chronic disease (e.g. chronic pain, hypertension, heart disease, renal disease, liver disease, diabetes)
* Current medications (e.g. psychoactive medication, narcotics, intake of analgesics) or being currently in psychological or psychiatric treatment
* Current or regular drug consumption (THC (24h before visit), cocaine, heroin, etc.)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Karin Hediger
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Karin Hediger
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Basel
Basel, Canton of Basel-City, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-00206
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.